- Clinical Significance of the Urinary Bladder Cancer Antigen (UBCTM) Test in the Diagnosis of Bladder Cancer
-
Moon YC, Ryu DS, Oh TH
- KMID: 2292518
- Korean J Urol.
- 2002 Dec;43(12):1024-1028.
PURPOSE: A new quantitative tumor marker, based on the combined measurement of urinary fragments of cytokeratin 8 and 18, namely the urinary bladder cancer antigen (UBCTM) test, has been proposed... -
- CITED
-
- Close
- SHARE
-
- Close
- Time-course Transcriptional Profiling of Human Amniotic Fluid-derived Stem Cells Using Microarray
-
Kim YW, Kim HJ, Bae SM, Kim YJ, Shin JC, Chun HJ, Rhie JW, Kim J, Kim H, Ahn WS
- KMID: 2165963
- Cancer Res Treat.
- 2010 Jun;42(2):82-94.
PURPOSE: To maintain the homeostasis of stem cells and prevent their ability to initiate tumorigenesis, it is important to identify and modify factors that prevent or accelerate stem cell senescence.... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Value of Serum Cytokeratin 8, 18 and 19 in Lung Cancer
-
Choi CM, Kim WJ, Oh JY, Kang YA, Yoo CG, Lee CT, Kim YW, Han SK, Shim YS
- KMID: 2318434
- Tuberc Respir Dis.
- 2003 Oct;55(4):388-394.
BACKGROUND: Monoclonal antibodies directed against well-known epitopes on cytokeratin (CK) 8, 18 and 19 (Monototal) have been used in the development of a new diagnostic tool for lung cancer. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Application of Serum CEA, SCC, Cyfra2l-1, and TPA in Lung Cancer
-
Lee JH, Kim KC, Lee SJ, Lee JK, Jo SJ, Kwon KY, Han SB, Jeon YJ
- KMID: 2318058
- Tuberc Respir Dis.
- 1997 Aug;44(4):785-795.
BACKGROUND: Tumor markers have been used in diagnosis, predicting the extent of disease, monitering recurrence after therapy and prediction of prognosis. But the utility of markers in lung cancer has... -
- CITED
-
- Close
- SHARE
-
- Close
